3,511 results found

Teva Pharmaceutical Industries and Samsung Bioepis have announced a strategic partnership to commercialize OPUVIZ, a biosimilar referencing EYLEA, in the Canadian market. The agreement divides responsibilities between Samsung Bioepis handling product registration and manufacturing while Teva Canada leads commercialization efforts. OPUVIZ has already received Health Canada approval for treating multiple eye conditions including wet age-related macular degeneration and diabetic macular edema.

This week, the Canadian government released "Proposed Regulations Amending the Cannabis Regulations and Proposed Order Amending Schedules 3 & 4 to the Cannabis Act" ...

Montréal-based healthtech startup, Ditch Labs, has acquired a portfolio of patents from Enovap SAS, a France-based e-cigarette company for an undisclosed amount...

The appellants argued that Apo-Lansoprazole could not and would not have received regulatory approval in April 2007 and Apotex was not entitled to damages.

In a unanimous decision released November 8, 2012, the Supreme Court of Canada cleared the way for an affordable generic version of Pfizer’s Viagra to be sold in Canada by Teva Canada Ltd.

There seems to be a trend developing in United States courts to place limits on class actions, including class proceedings involving pharmaceutical and medical products, but the same cannot be said regarding courts in Canada.

In a consent agreement reached with the Competition Bureau, Teva Pharmaceutical Industries Ltd. has agreed to divest assets related to two pharmaceutical products in order to complete its acquisition of Allergan plc in Canada.

Following concerns that Pfizer Inc.'s proposed acquisition of Hospira Inc. will result in a substantial lessening of competition, Pfizer has reached an agreement with the Competition Bureau to sell the Canadian assets related to four pharmaceutical products distributed by the pharma giant in Canada.

The City of Toronto bylaw that was passed in December 2015 to ban hookah pipes in city-licensed establishments has recently survived a challenge at Ontario's top court.

Dans l'épisode 2 : La médecine des populations, Emmanuelle Poupart s'entretient avec le directeur de santé publique de l'Estrie, le Dr Alain Poirier, des mesures prises par le gouvernement dans le cadre de l'urgence sanitaire ...

On June 19, 2019, Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC) announced that it had completed its previously announced acquisition of NettaGrowth

On July 8, 2019, SOL Global Investments Corp. announced that it had completed a $50 million private placement financing by way of the issue and sale of a senior secured non-convertible debenture...

By way of a 52-29 vote, the Canadian Senate has now passed the federal government's bill legalizing recreational marijuana in Canada.

The occupational health and safety risks associated with farming have long been known. The introduction of recreational (legalized) cannabis

As we previously reported, the new Smoke-Free Ontario Act, 2017 (SFOA) was to come into force on July 1, 2018.

Prime Minister Trudeau announced today that the legislation will take effect on October 17, 2018.

Close to 90% of respondents had no personal experience with accommodating an employee who used medical marijuana.

Mr. Justice Paul Belzil in the Alberta Court of Queen's Bench has granted Unifor an injunction blocking Suncor's random drug testing policy for its oilsands facilities in northeastern Alberta.